Your browser doesn't support javascript.
loading
Long-term growth rate of vestibular schwannoma in neurofibromatosis 2: A volumetric consideration.
Picry, Aurore; Bonne, Nicolas-Xavier; Ding, Juliette; Aboukais, Rabih; Lejeune, Jean-Paul; Baroncini, Marc; Dubrulle, Frédérique; Vincent, Christophe.
Afiliação
  • Picry A; Department of Otology and Neurotology, Roger Salengro Hospital, Lille University Hospital, Lille, France. aurore.picry@chru-lille.fr.
  • Bonne NX; Department of Anatomy, "Henri Warembourg" Faculty of Medicine, University of Lille, Lille, France. aurore.picry@chru-lille.fr.
  • Ding J; Department of Otology and Neurotology, Roger Salengro Hospital, Lille University Hospital, Lille, France.
  • Lejeune JP; Department of Neurosurgery, Roger Salengro Hospital, Lille University Hospital, Lille, France.
  • Baroncini M; Department of Neurosurgery, Roger Salengro Hospital, Lille University Hospital, Lille, France.
  • Dubrulle F; Department of Neurosurgery, Roger Salengro Hospital, Lille University Hospital, Lille, France.
  • Vincent C; Department of Radiology, Claude Huriez Hospital, Lille University Hospital, Lille, France.
Laryngoscope ; 126(10): 2358-62, 2016 10.
Article em En | MEDLINE | ID: mdl-27075822
ABSTRACT
OBJECTIVES/

HYPOTHESIS:

To determine the long-term growth rate of vestibular schwannoma (VS) in neurofibromatosis type 2 (NF2) patients based on volumetric measurements. STUDY

DESIGN:

Retrospective review.

METHODS:

We retrospectively reviewed magnetic resonance imaging (MRI) scans acquired from patients with NF2 from 1999 to 2013. Patients with an annual radiologic follow-up over at least 3 consecutive years were included. Volumetric VS growth was prospectively measured using a three-dimensional imaging workstation and through manual contouring of the lesion. Time to tumor progression was assessed according to the Response Evaluation in Neurofibromatosis and Schwannomatosis Tumor Measurement Group.

RESULTS:

Eighteen patients presenting with a total of 26 VSs were included. The mean age at diagnosis was 26.1 years (range, 7 to 49 years). One hundred five MRI scans were analyzed during a median radiological follow-up of 5.6 years (range, 3 to 12 years). The annual volume and diameter growth rates were respectively 218.3 mm(3) /yr (range, -10 to 1,250 mm(3) /yr) and 0.9 mm/yr (range, -0.5 to 4.5 mm/yr). Time to tumor progression was 3 years (median survival). There was a weak correlation between volumetric and linear measurements (P < .0001, linear regression, n = 26, r(2) = 0.58). Among the 26 VSs, 76.9% (20/26) showed progression (VS growth more than 20%), 19.2% were stable, and 3.9% (1/26) exhibited shrinkage (spontaneous regression of more than 20% of the initial volume).

CONCLUSIONS:

This study helps to assess the long-term growth profile of VS in a population of NF2 patients with untreated VS. These data could help to better acknowledge VS natural growth history. LEVEL OF EVIDENCE 4 Laryngoscope, 1262358-2362, 2016.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuroma Acústico / Neurofibromatose 2 Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuroma Acústico / Neurofibromatose 2 Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article